AI assistant
Sending…
Moleculin Biotech, Inc. — Director's Dealing 2022
Mar 3, 2022
34881_dirs_2022-03-02_78937c83-961e-4eb0-9c33-a01771ccc37e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2022-03-01
Reporting Person: Yan Joy (Director)
More from Moleculin Biotech, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 15